3d systems and collplant enter co-development agreement to deliver bioprinted solutions for improved breast reconstruction treatments

Rock hill, s.c. and rehovot, israel, june 22, 2021 (globe newswire) -- today, 3d systems (nyse:ddd) and collplant biotechnologies (nasdaq:clgn) announced they have signed a co-development agreement for a 3d bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant. the soft tissue matrix is intended to support the lower portion of the breast while expanding the implant pocket and providing increased coverage of the implant. using 3d bioprinting, these matrices can be designed to match the patient's anatomy to support the breast implant.
DDD Ratings Summary
DDD Quant Ranking